Finalists of the Blue Tulip Awards Generation 4 announced: these are the top…
For the past two years, the need for innovation has been more clear than ever.
Technology, AI, capital and institutions, examined through who builds systems, who controls them and who benefits.
11,488 articles · Technology & Power
For the past two years, the need for innovation has been more clear than ever.
London’s startup ecosystem is by far the largest in Europe with a total value of $142.7B.
Lyre's, a London-based producer of non-alcoholic spirits, announced that it has secured £20M (approx €23.6M) funding at a valuation of £270M (approx €319M), up from a valuation of £100M earlier this year.
French Healthtech startup Lifen, today, has announced that it has raised €50M funding in a Series C round led by Creadev and Lauxera Capital Partners, with participation from existing investors Partech and Serena.
TIER will acquire the shares from the previous majority shareholder Co-Investor Partners, and all other shareholders in an all-cash transaction.
Zip is a fintech company that provides fair, flexible, and transparent payment options to individual consumers and SMBs.
Vianova, a Paris-based urban mobility management platform, announced that it has secured $3M (approx €2.6M) funding in the Seed round.
Nuritas, a Dublin-based biotechnology company that uses proprietary AI to discover plant-based bioactive peptides, announced that it has secured $45M (approx €39M) funding in the Series B round.
Valo Therapeutics is an immuno-oncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.
30MHz builds both hardware and software in collaboration with and for the benefit of the agricultural sector.
MyLife Technologies, a Leiden-based vaccine and drug delivery startup focusing on ceramic vaccine patches for painless administration through the skin, have raised $4M (approx €3.5M).
Pigment claims to overhaul the painful experience of using error-prone spreadsheets and inflexible software to forecast the future of business.